ID: ALA2315301

Max Phase: Preclinical

Molecular Formula: C13H16N2S2

Molecular Weight: 264.42

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  c1ccc2[nH]c(SSC3CCCCC3)nc2c1

Standard InChI:  InChI=1S/C13H16N2S2/c1-2-6-10(7-3-1)16-17-13-14-11-8-4-5-9-12(11)15-13/h4-5,8-10H,1-3,6-7H2,(H,14,15)

Standard InChI Key:  XXLFTWNQPCRCES-UHFFFAOYSA-N

Associated Targets(Human)

Thioredoxin 111 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 264.42Molecular Weight (Monoisotopic): 264.0755AlogP: 4.64#Rotatable Bonds: 3
Polar Surface Area: 28.68Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.82CX Basic pKa: 3.67CX LogP: 4.68CX LogD: 4.68
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.82Np Likeness Score: -1.07

References

1. DiRaimondo TR, Plugis NM, Jin X, Khosla C..  (2013)  Selective inhibition of extracellular thioredoxin by asymmetric disulfides.,  56  (3): [PMID:23327656] [10.1021/jm301775s]

Source